The governance
- The management
- Our founders
- Board of directors
- The executive committee
- The council of the IHU
- The scientific council
The managementProf. Stéphane Hatem has been Managing Director of IHU ICAN since 2018. He was unanimously reappointed by the Board of Directors on December 16, 2021 for a 4-year term.
He is assisted by Stéphane Barritault, General Secretary, in charge of the Institute’s operational management.
This duo at the helm of the IHU is supported by a management committee made up of 6 divisions:
- Innovation and Research Development
- Platforms and Business Development Division
- Clinical Research Center: MRI & Corelab Imaging Center and Cardiometabolic Diseases Clinical Investigation Center
- Legal, Compliance and Data Policy Department
- Administration, HR and Finance Department
- Communication and Sponsorship Department
Joëlle Pfeffer : Executive AssistantOur foundersTo carry out its mission, IHU ICAN draws on the expertise of its founding members: Assistance Publique Hôpitaux de Paris (AP-HP), Institut National de la Santé et de la Recherche Médicale (INSERM) and Sorbonne Université (SU).Board of directorsThe IHU is steered by a board of directors (CA) which defines its general policy.
It is made up of 16 members, 6 founding members, 5 qualified personalities, 3 representatives from the economic world and 2 representatives elected by teacher-researchers. The Board is chaired by Anne-Marie Armanteras.Anne-Marie ARMANTERASChairman of the Board, IHU ICANGraduate ofEcole des Hautes Etudes en Santé Publique – EHESP, she worked as head of a hospital establishment, then as Île-de-France regional delegate for the Fédération des établissements hospitaliers et d’aide à la personne (FEHAP).
She has also held positions of great responsibility in the healthcare system, heading up the Healthcare Establishments Division and the Healthcare and Medico-social Services Division of theAgence Régionale de Santé (ARS) Île-de-France from 2013 to 2016 and as Director General of Healthcare Services (DGOS) at the Ministry of Health and Social Affairs from April 2016 to April 2017.
A member of the Collège de la Haute Autorité de Santé in 2017, she was then appointed health advisor for “health, disability and the elderly” to the President of the Republic, a position she held from March 2020 to June 2022.
It has also been commissioned to propose “a plan to renovate biomedical research” by the ministers of health, industry, higher education and research in 2023.
Currently President of the Think Tank Health & Tech, she is also Chairman of the Board of ANAP (Agence nationale pour la performance sanitaire et médico-sociale).Representatives of the foundersNicolas REVELManaging Director AP-HPDidier SAMUELChairman and CEO INSERMNathalie DRACH-TEMAMPresident Sorbonne UniversityMilan LAZAREVICDirector of Clinical Research and Innovation AP-HPElli CHATZOPOULOUDirector of the Department of Partnerships and External Relations INSERMBruno RIOUDean of the Faculty of MedicineQualified personalitiesCatherine BoileauAP-HP – PUPH Claudine CANALEPresident of “Les Poids Plume France” Stanislav DUSKO EHRLICHResearch Director, INRIAJulien ETTERSPERGERCEO MEDICEN, Paris RegionRepresentatives of the economic worldLaurence COMTE ARASSUSGE Healthcare, General Manager, FBFA zone, Representative of SNITEMPierre SONIGOSEBIA, Chief ScientistPhilip JANIAKCorteria Pharmaceuticals, CEORepresentatives of researchers, teacher-researchersCorinne FREREMCU-PH, Biological Hematology, AP-HPBruno FEVECRSA, UMR-S 938The executive committeeThe Executive Committee (COMEX) of the IHU is made up of the Director General, the Secretary General, the heads of the IHU’s internal poles and one community representative per strategic axis. The director of the Pitié-Salpêtrière Hospital Group and the medical director of the DMU are permanent guests. The COMEX is responsible for assisting the Director General, particularly in defining the IHU’s strategy and scientific orientations, but also in all aspects of management.
The Chief Executive Officer is appointed for 4 years by the Chairman of the Board of Directors, from among the candidates proposed by the Board. The Director General is responsible for the general management of the IHU. He is assisted by a Secretary General in charge of the operational management of the Institute.Prof. Judith ARON-WISNEWSKYEndocrinology and metabolismProf. Olivier BOURRONEndocrinology and metabolismLoic CARBADILLODirector of Research, Innovation and Rare Diseases AP-HP Sorbonne UniversityProf. Philippe CHARRONHead of the Genomics and Pathophysiology of Myocardial Diseases Research Team UMR 1166 and Director of the Reference Center for Cardiomyopathies and Hereditary Heart Rhythm DisordersProf. Alain CombèsIntensive medicine-resuscitationDr Laurie DUFOURCardiology and vascular diseasesProf. Bruno FEVEDirector of research unit 938 – Saint-Antoine research centerDr Antonio GALLOEndocrinology and metabolismProf. Estelle GANDJBAKHCHCardiology and vascular diseasesProf. Richard ISNARDCardiology and vascular diseasesDr Wilfried LE GOFFTeam leader, Systemic and cellular lipid metabolism in cardiometabolic diseases (UMR_S1166)Prof. Irene NETCHINEPhysiology – Pediatric functional explorationsProf. Vlad RATZIUGastroenterology and hepatologyProf. Alban REDHEUILCardiovascular imagingThe council of the IHUThe IHU board is made up of the general director of the IHU, the general secretary, the dean of the Sorbonne University faculty of medicine, the directors and team leaders of the UMRs involved in the ICAN, the medical director of the DMU Archimede, department heads of this DMU involved in the clinical activities of ICAN. The Chairman of the IHU Council is the Chief Executive Officer of the IHU. Its objective is to strengthen the internal cohesion of the medical and scientific community of the IHU and to allow a fluidity of information between the teams to ensure overall consistency. The purpose of the IHU council is to allow discussion and sharing on the strategic orientations and scientific policy of the IHU.Prof. Zahir AMOURAHead of the internal medicine department of the Pitié-Salpêtrière hospitalElise BALSEHead of the Molecular and Cellular Plasticity in Cardiovascular Diseases team – UMR 1166Prof. Eric BRUCKERTHead of the Department of Endocrinology, Metabolism and Prevention of Cardiovascular DiseasesProf. Philippe CHARRONHead of the Genomics and Pathophysiology of Myocardial Diseases Research Team UMR 1166 and Director of the Reference Center for Cardiomyopathies and Hereditary Heart Rhythm DisordersProf. Laurent CHICHÉHead of the Cardiovascular Surgery Department at Saint Antoine HospitalProf. Sophie CHRISTIN-MAITREHead of the Endocrinology, Diabetology and Reproductive Medicine Department at Saint-Antoine HospitalProf. Karine CLEMENTHead of UMR 1269 Nutriomics – Nutrition and obesityProf. Ariel COHENHead of the Cardiology Department at Saint Antoine HospitalDr Michel ZEITOUNIHead of Interventional Cardiology Unit of the GH PSL Cardiology Institute, Head of Team 2 Atherothrombosis and Applied Pharmacology – UMR 1166Prof. Alain CombèsHead of the resuscitation department at the Pitié-Salpêtrière hospitalProf. Bruno FEVEDirector of research unit 938 – Saint-Antoine research centerFabienne FOUFELLEHead of the metabolic diseases, diabetes and comorbidities team – UMR 1138 Cordeliers research centerProf. Christian FUNCK-BRENTANOHead of the Paris-Est Clinical Investigation Center (CIC)Prof. Agnes HARTEMANNHead of the diabetology department at IE3MProf. Chantal HOUSSETHead of the team Fibroinflammatory diseases of metabolic and biliary origin of the liver – Research unit 938 – Saint-Antoine research centerProf. Richard ISNARDHEAD OF DMU ARCHIMEDENadjia KACHENOURACardiovascular imaging team leader UMR 1146Wilfried LE GOFFTeam leader Cellular lipid metabolism in cardiovascular diseases – UMR 1166Prof. Laurence LEENHARDTHead of the Functional Unit for Thyroid and Endocrine Tumor PathologiesProf. Pascal LEPRINCEHead of the Department of Cardiac Surgery at the Heart Institute of the Pitié-Salpêtrière Hospital GroupPhilippe LESNIKHead of the Mononuclear phagocytes in metabolic diseases team – UMR116Sophie NADAUDHead of the Molecular and Cellular Plasticity in Cardiovascular Diseases team – UMR 1166Prof. Irene NETCHINEHead of the IGF system, fetal and postnatal growth team – Research unit 938 – Saint-Antoine research centerProf. Michael OPPERTHead of the nutrition department of the E3M institute and the human nutrition research center (CRNH)Prof. Christine POITOU-BERNERTNutrition – Genetic Rare Obesity Reference CenterProf. Alban REDHEUILHead of Cardiovascular Imaging Unit of the Heart Institute of the Pitié-Salpêtrière Hospital GroupProf. Bruno RIOUDean of the Faculty of MedicineProf. Philippe TOURAINEHead of Endocrinology and Reproductive MedicineProf. Corinne VIGOUROUXReference center for rare pathologies of insulin-secretion and insulin-sensitivity (PRISIS)The scientific councilThe scientific council of ICAN is composed of 5 external personalities, highly recognized by the international scientific community, in the field of cardiometabolism and nutrition. This scientific governance body, appointed by the Board of Directors, is consulted on the main scientific orientations and the annual action program of the IHU. The scientific council also evaluates the scientific performance of the Foundation. He is very involved in the scientific life of ICAN and plays a fundamental role in it.Prof. Karin SIPIDO – Chairman of the Scientific Advisory BoardProfessor of Medicine and Head of Experimental CardiologyUniversité de Louvain
Belgium“ICAN is an ambitious, forward-looking, international centre of excellence at the cutting edge of cardiometabolic research. Its work in this field is highly relevant, given the current rise in obesity, diabetes and cardiovascular diseases. The ICAN approach is unique in that it focuses on communication between organs.
The Scientific Advisory Board was particularly pleased to note the depth and scope of ICAN’s research, which draws on advanced technological platforms to collect and use a multitude of data, linking basic and clinical research to optimise the application of results. Early and mid-career scientists who attended the meeting emphasised that the future of the ICAN mission is bright.”
Pr Karine SIPIDO, Présidente du Conseil scientifiqueProf. André CARPENTIERFaculté de médecine et des sciences de la santé de l’Université de Sherbrooke
CanadaDirector of the “Diabetes, obesity and cardiovascular complications” research axisPr Michel KOMAJDAProfessor of Cardiology and Chairman of the Heart & Research FoundationGroupe hospitalier Paris Saint-Joseph, Paris Sorbonne Université
FranceDr David SAVAGEBiochemist-endocrinologist, Fat tissue biology
Institute of Metabolic Science, Cambridge University Hospitals
Royaume-UniProf. Rozemarijn VLIEGENTHARTRadiologist and Professor of Cardiothoracic ImagingCentre médical universitaire de Groningue
Pays-BasProf. Arnold VON ECKARDSTEINClinical Biochemistry, Laboratory Medicine and PathologyCentre universitaire de médecine de laboratoire et de pathologie (UZL)
Suisse
